Figure 8
From: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
The role of Tat in RVX-208 and PFI-1-mediated activation of latent HIV-1. TZMbl cells were transfected with control or Tat expressing vector, and then received RVX-208 (50 μM) or PFI-1 (5 μM) treatment. Lysates were examined for luciferase activity and depicted as fold increase relative to control.
